share_log

凯赛生物(688065.SH):部分超长链二元酸品种可用于多肽类药物的侧链修饰

Cathay Biotech Inc. (688065.SH): Some ultra-long chain dicarboxylic acid varieties can be used for side chain modification of peptide drugs.

Gelonghui Finance ·  Sep 18 00:58

Gelonghui, September 18th, Cathay Biotech Inc. (688065.SH) stated on the investor interaction platform that some of the company's ultra-long-chain diacid varieties can be used for side chain modification of peptide drugs, providing long-acting sustained release effects. The company is also actively paying attention to related business opportunities, hoping to create more commercial value with its many years of technical accumulation in synthetic biology.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment